Pharma Research Products Co., Ltd (214450)
KRX
Closed
Aug 25, 2026
Day's Range
403,500.0052 wk Range
255,000.00Overview - 214450 - Pharma Research Products Co., Ltd
Key Statistics
Valuation
Enterprise Value
3.94T
P/E (Trailing)
‪26.08‬
P/E (Forward)
‪17.57‬
PEG Ratio
‪0.82‬
Price / Sales (TTM)
‪7.52‬
Price / Book
‪5.87‬
EV / EBITDA
‪16.32‬
Profitability
Gross Margin
‪77.29%‬
Profit Margin
‪31.21%‬
Operating Margin
‪39.40%‬
Return on Assets
‪14.25%‬
Return on Equity
‪27.25%‬
Ownership
Shares Outstanding
10.38M
Float
5.57M
Held by Insiders
‪34.96%‬
Held by Institutions
‪15.48%‬
Price stats
Beta
‪0.45‬
50-Day Avg
‪350,400.00‬
200-Day Avg
‪362,122.50‬
Dividends
Payout Ratio
‪21.20%‬
Frequency
Annual
Analyst Consensus
14 analysts
Average price target
‪₩ 508,357.16‬Market Cap - 214450 - Pharma Research Products Co., Ltd
Peers - 214450 - Pharma Research Products Co., Ltd
Peer Comparison
Compared with companies in Biotechnology listed on KRX.
Profile Summary - 214450 - Pharma Research Products Co., Ltd
About
PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
